Pacifica Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Hold
328
0.12% 88
2026
Q1
$302K Hold
328
0.1% 94
2025
Q4
$354K Buy
328
+16
+5% +$15.3K 0.16% 75
2025
Q3
$258K Buy
312
+8
+3% +$5.95K 0.09% 102
2025
Q2
$236K Hold
304
0.1% 101
2025
Q1
$240K Buy
304
+9
+3% +$7.49K 0.11% 91
2024
Q4
$229K Sell
295
-115
-28% -$95.2K 0.1% 96
2024
Q3
$363K Sell
410
-55
-12% -$49.4K 0.15% 83
2024
Q2
$418K Sell
465
-195
-30% -$156K 0.18% 72
2024
Q1
$510K Sell
660
-31
-4% -$22.1K 0.23% 67
2023
Q4
$406K Buy
691
+170
+33% +$99.2K 0.2% 72
2023
Q3
$282K Buy
521
+500
+2,381% +$258K 0.15% 80
2023
Q2
$9.78K Hold
21
0.01% 300
2023
Q1
$7.7K Hold
21
﹤0.01% 344
2022
Q4
$7.67K Hold
21
0.01% 311
2022
Q3
$6K Hold
21
﹤0.01% 351
2022
Q2
$7K Hold
21
﹤0.01% 340
2022
Q1
$5K Hold
21
﹤0.01% 376
2021
Q4
$5K Buy
+21
New +$5.32K ﹤0.01% 365

Other funds holding LLY

Pacifica Partners's LLY Position: Q2 2026 in Review

Pacifica Partners held its Eli Lilly (LLY) position steady in Q2 2026 at 328 shares worth $397K. The position accounts for 0.12% of the portfolio, ranked #88.

Pacifica Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $510K in Q1 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pacifica Partners held 328 shares of Eli Lilly worth $397K as of Q2 2026.
  • Pacifica Partners left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.12% of Pacifica Partners's portfolio in Q2 2026, its #88 holding.
  • Pacifica Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Pacifica Partners's Eli Lilly position peaked at $510K in Q1 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.